EPCAM and cancer: EpCAM+ITGAV+ cancer cells gave rise to MD/PD-SCCs containing a higher percentage of mesenchymal EpCAMneg and ITGAV+ cancer cells than EpCAM+ITGAV−-derived tumors (Fig. 2A-C).